Literature DB >> 35478009

Moderate prenatal alcohol exposure modifies sex-specific CRFR1 activity in the central amygdala and anxiety-like behavior in adolescent offspring.

Siara Kate Rouzer1,2, Marvin R Diaz3,4.   

Abstract

Anxiety disorders are highly prevalent among individuals with a history of prenatal alcohol exposure (PAE), and adolescent rodents demonstrate anxiety-like behavior following moderate PAE on Gestational Day (G) 12. A likely systemic target of PAE is the stress peptide corticotropin-releasing factor (CRF), as activation of CRF receptor 1 (CRFR1) in the medial nucleus of the central amygdala (CeM) is known to increase anxiety-like behavior in adults. To determine if CRF-CRFR1 interactions underly PAE-induced anxiety, functional changes in CRF system activity were investigated in adolescent male and female Sprague Dawley rats following G12 PAE. Compared to air-exposed controls, PAE increased basal spontaneous (s) inhibitory postsynaptic current (IPSC) frequency in the CeM of males, but not females. Furthermore, PAE blunted CRFR1-regulated miniature (m) IPSCs in a sex- and concentration-specific manner, and only PAE males demonstrated tonic CRFR1 activity in the CeM. It was further determined that G12 PAE decreased CRFR1 mRNA in the CeM of males while increasing regional expression in females. Finally, infusion of a CRFR1 agonist into the CeM of adolescents produced a blunted expression of CRFR1-induced anxiety-like behavior exclusively in PAE males, mirroring the blunted physiology demonstrated by PAE males. Cumulatively, these data suggest that CRFR1 function within the CeM is age- and sex-specific, and PAE not only increases the expression of anxiety-like behavior, but may reduce the efficacy of treatment for PAE-induced anxiety through CRFR1-associated mechanisms. Therefore, future research will be necessary to develop targeted treatment of anxiety disorders in individuals with a history of PAE.
© 2022. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35478009      PMCID: PMC9556708          DOI: 10.1038/s41386-022-01327-z

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  45 in total

1.  Calbindin-D28k immunoreactivity in the rat amygdala.

Authors:  A J McDonald
Journal:  J Comp Neurol       Date:  1997-06-30       Impact factor: 3.215

2.  The Central Amygdala Corticotropin-releasing hormone (CRH) Neurons Modulation of Anxiety-like Behavior and Hippocampus-dependent Memory in Mice.

Authors:  Tanvi Paretkar; Eugene Dimitrov
Journal:  Neuroscience       Date:  2018-08-29       Impact factor: 3.590

Review 3.  The mouse light/dark box test.

Authors:  Michel Bourin; Martine Hascoët
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

4.  CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling.

Authors:  Ana C Magalhaes; Kevin D Holmes; Lianne B Dale; Laetitia Comps-Agrar; Dennis Lee; Prem N Yadav; Linsay Drysdale; Michael O Poulter; Bryan L Roth; Jean-Philippe Pin; Hymie Anisman; Stephen S G Ferguson
Journal:  Nat Neurosci       Date:  2010-04-11       Impact factor: 24.884

5.  The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.

Authors:  T Shimada; K Matsumoto; M Osanai; H Matsuda; K Terasawa; H Watanabe
Journal:  Gen Pharmacol       Date:  1995-01

Review 6.  Psychiatric conditions associated with prenatal alcohol exposure.

Authors:  Mary J O'Connor; Blair Paley
Journal:  Dev Disabil Res Rev       Date:  2009

Review 7.  The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders.

Authors:  John H Kehne
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

8.  Risky choice and brain CRF after adolescent ethanol vapor exposure and social stress in adulthood.

Authors:  Nathalie Boutros; Andre Der-Avakian; Svetlana Semenova; Soon Lee; Athina Markou
Journal:  Behav Brain Res       Date:  2016-05-20       Impact factor: 3.332

9.  (3α,5α)3-hydroxypregnan-20-one (3α,5α-THP) regulation of hypothalamic and extrahypothalamic corticotropin releasing factor (CRF): Sexual dimorphism and brain region specificity in Sprague Dawley rats.

Authors:  Giorgia Boero; Ryan E Tyler; Caroline A Todd; Todd K O'Buckley; Irina Balan; Joyce Besheer; A Leslie Morrow
Journal:  Neuropharmacology       Date:  2021-01-16       Impact factor: 5.250

10.  Fetal Alcohol Spectrum Disorders in a Midwestern City: Child Characteristics, Maternal Risk Traits, and Prevalence.

Authors:  Philip A May; Julie M Hasken; Amy Baete; Jaymi Russo; Amy J Elliott; Wendy O Kalberg; David Buckley; Marita Brooks; Marian A Ortega; Dixie M Hedrick; Barbara G Tabachnick; Omar Abdul-Rahman; Margaret P Adam; Tamison Jewett; Luther K Robinson; Melanie A Manning; H Eugene Hoyme
Journal:  Alcohol Clin Exp Res       Date:  2020-04-15       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.